InspireMD, Inc. announced on June 3, 2025, the appointment of Michael Lawless as its new Chief Financial Officer, effective on or prior to June 30, 2025. Mr. Lawless, an industry veteran with decades of financial leadership in healthcare, will succeed Craig Shore, who served as CFO for nearly 15 years.
Mr. Lawless previously served as CFO of Lifeward (formerly ReWalk Robotics) for three years and as CFO of the Life Sciences unit of Brooks Automation. His experience as a public company CFO is expected to be crucial as InspireMD enters its next phase of growth, including the pending launch of CGuard Prime in the U.S. market.
CEO Marvin Slosman expressed enthusiasm for Mr. Lawless's expertise and experience to lead the company's commercial evolution. In connection with his appointment, Mr. Lawless will receive an inducement grant of 465,000 shares of restricted stock and stock options to purchase 212,000 shares of common stock, vesting over three years.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.